Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/CTOR/Gross margin

Citius Oncology, Inc. (CTOR) Gross margin

Citius Oncology, Inc. (CTOR) gross margin by fiscal year — reported gross profit divided by reported revenue.

No annual history for this metric yet

The company may have no SEC filings (ETF / non-US listing), or the concept is absent from its filings.

← Back to CTOR

Source: SEC XBRL filings · For reference only · Not investment advice

More CTOR financial trends

CTOR RevenueCTOR Net incomeCTOR Net marginCTOR Gross profitCTOR Operating incomeCTOR Operating marginCTOR Operating cash flowCTOR Free cash flowCTOR Capital expendituresCTOR Return on equityCTOR Stock buybacksCTOR Dividends paidCTOR Total assetsCTOR Total liabilitiesCTOR Shareholders’ equityCTOR overview →